Valuation models
price $76.57 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused75.92 – 125.1795.1520% undervaluedDCF · Perpetuity growth · 10y82.05 – 134.60102.5825% undervaluedDCF · EBITDA exit · 5y136.82 – 150.34143.4047% undervaluedDCF · EBITDA exit · 10y131.94 – 157.23143.9747% undervaluedP/E · peers82.07 – 106.8094.2019% undervaluedP/E · own history77.20 – 117.0485.4010% undervaluedPEG—53.9142% overvaluedEV/EBITDA · peers80.66 – 110.15106.4228% undervaluedEV/Revenue · peers106.65 – 167.25156.6751% undervaluedEarnings power value40.96 – 67.0651.4349% overvaluedDividend discount2.84 – 6.634.221714% overvaluedWall St. consensus target—84.509% belowCost of capital (WACC)—7.58%—
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
95.15
GE HealthCare closed at $76.57 — undervalued by 20% vs model.
75.92the model's range125.17
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
4.22 – 156.67
Wall St. target
84.50 9% below
Below model, 1y
30 of 30 days
How it is valued
Valued asMature & stable
Low/slowing growth (~3% recent)Moderate margins (10% net margin)Highly cyclical earnings
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.